CONFERENCE ON PREVENTION AND TREATMENT OF AIDS

在过去的三到五年里，Keystone会议一直是 人类逆转录病毒领域的主要国际会议和 艾滋病。他们的声望并不在于选题或 演讲者，但在他们的设计中提供了一个独特的演示论坛 在讨论和辩论的同时提供新的信息。因为 艾滋病流行的严重性，这些会议不仅有 基础科学的最新进展，也是最重要的 疾病预防和治疗方法的发展。 1992年“艾滋病毒和艾滋病：发病机制、疫苗和 治疗“，不仅将延续这一传统，而且实际上是为了 进一步加强信息互通。该格式将以 为涵盖一般主题而设计的全体讲座与相关 研讨会和海报会议。这些会议中的每一个都将是非 同时进行，以便全员出席。更重要的是， 发言人数和发言次数将使更多 将有机会进行讨论和辩论。因此，每一天 在为期六天的会议中，将专门讨论艾滋病的广泛部分 研究如下：第一天-病毒/宿主细胞相互作用；第二天- “分子生物学”；第三天--“病毒发病机制”；第四天--“免疫反应” 应对艾滋病毒/SIV“；第5天--”疫苗研究进展“；第6天--”新战略“ 与过去一样，这种方法使人们能够并鼓励 不同兴趣和学科的调查人员，包括年轻的 科学家有效地参与和互动。 在这方面已经并将继续取得一些重要进展 艾滋病领域，将在1992年的Keystone会议上分别 以上概述的广泛领域中的一部分。特别的尘埃将会是更好的 对HIV多样性和遗传漂移的理解，HIV的机制 发病机制、疫苗研究的显著进展和新的 艾滋病毒感染和疾病的治疗进展。

Over the past three to five years, the Keystone Conferences have been among the premier international meetings in the field of human retroviruses and AIDS. Their prestige lies not so much in the selection of topics or speakers but in their design which provides a unique forum for presentation of new information accompanied by discussion and debate. Because of the seriousness of the AIDS epidemic, the conferences have featured not only the latest advances in basic science but also the all important developments in preventive and therapeutic approaches for the disease. The 1992 Keystone Conference "HIV and AIDS: PATHOGENESIS, VACCINES and THERAPY", will not only extend this tradition but is actually designed to further improve the exchange of information. The format will feature plenary lectures designed to cover a general topic accompanied related workshops and poster sessions. Each of these sessions will be non- concurrent such that full attendance will be available. Futhermore, the number of speakers and times of presentation will be such that even more opportunities for discussion and debate will be possible. Thus, each day of the six day conference will be devoted to a broad segment of AIDS research as follows: Day 1 - Virus/Host Cell Interactions; Day 2- "Molecular Biology"; Day 3- "Viral Pathogenesis"; Day 4- "Immune Responses to HIV/SIV"; Day 5- "Progress in Vaccine Research ";Day 6- "New Strategies for AIDS Treatment." As in the past, this approach enables and encourages investigators with different interests and disciplines, including young scientists to participate and interact effectively. A number of important advances have and will continue to be made in the AIDS field which will be featured at the 1992 Keystone Conference in each of the broad areas outlined above. Of particular mote will be a better understanding of HIV diversity and genetic drift, mechanisms of HIV pathogenesis, the remarkable progress in vaccine research and new developments for treatment of HIV infection and disease.